Scientists attack pancreatic cancer with Triple-Threat immune therapy before surgery
Disease control
Recruiting now
This study tests whether adding new immune-boosting drugs to standard radiation before surgery can help the body fight advanced pancreatic cancer more effectively. It will enroll 60 patients who have already completed initial chemotherapy and are candidates for surgery. Researche…
Phase: PHASE2 • Sponsor: Gulam Manji • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC